Samuel D. Shillcutt

1.7k total citations
43 papers, 1.2k citations indexed

About

Samuel D. Shillcutt is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Samuel D. Shillcutt has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 8 papers in Psychiatry and Mental health and 7 papers in Pharmacology. Recurrent topics in Samuel D. Shillcutt's work include Global Maternal and Child Health (7 papers), Child Nutrition and Water Access (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Samuel D. Shillcutt is often cited by papers focused on Global Maternal and Child Health (7 papers), Child Nutrition and Water Access (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Samuel D. Shillcutt collaborates with scholars based in United States, United Kingdom and India. Samuel D. Shillcutt's co-authors include Anne Mills, Catherine Goodman, Kerry L. Coburn, Damian Walker, P. G. Coleman, Chantal Morel, Edward C. Lauterbach, Mario F. Mendez, David S.H. Bell and C. W. M. Whitty and has published in prestigious journals such as Biological Psychiatry, Biochemical Pharmacology and Schizophrenia Bulletin.

In The Last Decade

Samuel D. Shillcutt

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel D. Shillcutt United States 20 322 236 160 141 117 43 1.2k
Melody Ryan United States 22 217 0.7× 240 1.0× 260 1.6× 71 0.5× 156 1.3× 77 1.4k
Georgios Papazisis Greece 27 397 1.2× 252 1.1× 268 1.7× 65 0.5× 80 0.7× 128 2.0k
Rachel Vickers‐Smith United States 17 222 0.7× 143 0.6× 110 0.7× 109 0.8× 50 0.4× 57 1.4k
Frank T. Leone United States 29 305 0.9× 129 0.5× 103 0.6× 204 1.4× 61 0.5× 133 2.9k
James Shearer United Kingdom 23 433 1.3× 167 0.7× 390 2.4× 138 1.0× 94 0.8× 81 2.0k
Ismaeel Yunusa United States 18 156 0.5× 193 0.8× 217 1.4× 32 0.2× 152 1.3× 90 1.4k
John A. Hermos United States 25 396 1.2× 118 0.5× 64 0.4× 120 0.9× 41 0.4× 52 2.0k
Daniel K. Nelson United States 21 546 1.7× 118 0.5× 77 0.5× 82 0.6× 43 0.4× 41 1.5k
Njideka Okubadejo Nigeria 21 187 0.6× 71 0.3× 251 1.6× 138 1.0× 523 4.5× 81 1.6k
Edgar H. Adams United States 21 553 1.7× 189 0.8× 183 1.1× 87 0.6× 19 0.2× 32 1.4k

Countries citing papers authored by Samuel D. Shillcutt

Since Specialization
Citations

This map shows the geographic impact of Samuel D. Shillcutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel D. Shillcutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel D. Shillcutt more than expected).

Fields of papers citing papers by Samuel D. Shillcutt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel D. Shillcutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel D. Shillcutt. The network helps show where Samuel D. Shillcutt may publish in the future.

Co-authorship network of co-authors of Samuel D. Shillcutt

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel D. Shillcutt. A scholar is included among the top collaborators of Samuel D. Shillcutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel D. Shillcutt. Samuel D. Shillcutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shillcutt, Samuel D., Amnesty LeFevre, Christa Fischer-Walker, et al.. (2017). Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India: an application of the net-benefit regression framework. Cost Effectiveness and Resource Allocation. 15(1). 9–9. 7 indexed citations
2.
LeFevre, Amnesty, et al.. (2017). Defining a staged-based process for economic and financial evaluations of mHealth programs. Cost Effectiveness and Resource Allocation. 15(1). 5–5. 18 indexed citations
3.
Shillcutt, Samuel D., Amnesty LeFevre, Christa L. Fischer Walker, et al.. (2016). Economic costs to caregivers of diarrhoea treatment among children below 5 in rural Gujarat India: findings from an external evaluation of the DAZT programme. Health Policy and Planning. 31(10). 1411–1422. 9 indexed citations
4.
Shillcutt, Samuel D., Amnesty LeFevre, Christa L. Fischer Walker, Robert E. Black, & Sarmila Mazumder. (2014). Protocol for the economic evaluation of the diarrhea alleviation through zinc and oral rehydration salt therapy at scale through private and public providers in rural Gujarat and Uttar Pradesh, India. Implementation Science. 9(1). 164–164. 3 indexed citations
5.
Gobbi, Gabriella, et al.. (2014). Melatonin. 6 indexed citations
6.
Shillcutt, Samuel D., et al.. (2012). Forecasting burden of long-term disability from neonatal conditions: results from the Projahnmo I trial, Sylhet, Bangladesh. Health Policy and Planning. 28(4). 435–452. 11 indexed citations
7.
8.
Lauterbach, Edward C., et al.. (2010). Psychopharmacological Neuroprotection in Neurodegenerative Disease: Assessing the Preclinical Data. Journal of Neuropsychiatry. 22(1). 8–18. 67 indexed citations
9.
Lauterbach, E. C., et al.. (2010). Psychopharmacological Neuroprotection in Neurodegenerative Disease: Assessing the Preclinical Data. Journal of Neuropsychiatry. 22(1). 8–18. 19 indexed citations
10.
Lauterbach, Edward C., Samuel D. Shillcutt, Jeff Victoroff, Kerry L. Coburn, & Mario F. Mendez. (2010). Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications. Journal of Neuropsychiatry. 22(2). 130–154. 19 indexed citations
11.
Shillcutt, Samuel D., Damian Walker, Catherine Goodman, & Anne Mills. (2009). Cost Effectiveness in Low- and Middle-Income Countries. PharmacoEconomics. 27(11). 903–917. 175 indexed citations
12.
Shillcutt, Samuel D., Chantal Morel, Catherine Goodman, et al.. (2008). Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bulletin of the World Health Organization. 86(2). 101–110. 183 indexed citations
13.
Mills, Anne, Samuel D. Shillcutt, Peter John Cusack Coleman, Claudine Morel, & Catherine Goodman. (2004). Adaptation of Acceptability Curves: Probabilistic Sensitivity Analysis According to Fixed Parameters. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 1 indexed citations
14.
15.
Wang, Zhongbiao, et al.. (2003). Phenotypic diversity of smooth muscle cells isolated from human intracranial basilar artery. Neuroscience Letters. 351(1). 1–4. 5 indexed citations
16.
17.
Hong, Tao, Liming Zhang, Manuel R. Castresana, Walter H. Newman, & Samuel D. Shillcutt. (1997). Response of Cultured Cerebral Artery Smooth Muscle Cells to the Nitric Oxide Vasodilators, Nitroglycerin and Sodium Nitroprusside. Journal of Neurosurgical Anesthesiology. 9(1). 58–64. 7 indexed citations
18.
Moore, Norman C., et al.. (1997). Positive Symptoms of Schizophrenia: Response to Haloperidol and Remoxipride is Associated with Increased Alpha EEG Activity. Human Psychopharmacology Clinical and Experimental. 12(1). 75–80. 8 indexed citations
19.
Hong, Tao, et al.. (1995). C-natriuretic peptide but not atrial natriuretic peptide increases cyclic GMP in cerebral arterial smooth muscle cells. Life Sciences. 56(26). 2357–2365. 6 indexed citations
20.
Shillcutt, Samuel D., et al.. (1989). Measurement of blood levels of neuroleptics and metabolites by combined high performance liquid chromatography-radioreceptor assay for D2 and sigma sites. Biochemical Pharmacology. 38(5). 831–836. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melody Ryan Breakdown of academic impact, for papers by Georgios Papazisis Breakdown of academic impact, for papers by Rachel Vickers‐Smith Breakdown of academic impact, for papers by Frank T. Leone Breakdown of academic impact, for papers by James Shearer Breakdown of academic impact, for papers by Ismaeel Yunusa Breakdown of academic impact, for papers by John A. Hermos Breakdown of academic impact, for papers by Daniel K. Nelson Breakdown of academic impact, for papers by Njideka Okubadejo Breakdown of academic impact, for papers by Edgar H. Adams
Rankless by CCL
2026